Skip to main content

Nicholas Donoghoe, M.D.

Senior Vice President, Portfolio Innovation

About Nicholas Donoghoe, M.D.

As Senior Vice President, Portfolio Innovation, Nicholas Donoghoe is responsible for leading the execution of strategies that increase AbbVie’s agility, streamline processes, and unlock the full potential of our portfolio.

Dr. Donoghoe joined AbbVie in 2019 in a newly created Innovation role to support cross-functional priorities across the company.  In 2020 he then led Global Strategy and Operations for Allergan Aesthetics with responsibility for pipeline strategy , research and analytics , customer service, and strategy.

In 2021 Nicholas was asked to lead Portfolio Innovation as he works side-by-side with the AbbVie executive team to define and implement transformational initiatives that directly impact short- and long-term goals and the future success of AbbVie.

Dr. Donoghoe views his work through a unique lens of business and scientific acumen, having served as a partner at McKinsey and holding an M.D. from Johns Hopkins University and a B.S. from Duke University. During his time at McKinsey, he served global clients across a broad range of geographies and therapeutic areas, including oncology, immunology, and neuroscience.  Dr. Donoghoe focused on maximizing the success of drug launches, through which and gained extensive experience working with AbbVie on Corporate, Commercial, Medical, and Business Development.